We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EQT:NYSEEQT Corporation Analysis

Data as of 2026-03-10 - not real-time

$62.23

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

EQT is trading at $62.23, comfortably above its 20‑day ($59.47) and 50‑day ($56.15) SMAs and just below the 52‑week high of $63.06, indicating a near‑term bullish bias. The 14‑day RSI of 67 and a bullish MACD histogram (+0.15) reinforce the upward momentum, while the nearest support sits at $55.12. Relative to its DCF fair value of $98.87, the market price is roughly 36% below intrinsic value, and the P/E of 18.8 is modestly under the industry average of 20.6, suggesting an undervalued position. Dividend yield stands at 1.06% with a low payout ratio of 19%, supported by robust free cash flow of $1.83 B, underscoring sustainability.
Fundamentally, EQT posted 27% revenue growth, a gross margin of 78.6% and an operating margin of 55%, driven by strong natural‑gas operations in the Appalachian Basin. The company announced a share‑repurchase program for up to 3 million shares and is part of a consortium eyeing the $33.4 B AES acquisition, which could add strategic scale. However, a debt‑to‑equity ratio of 28.9 and a beta of 0.67 highlight leverage and modest market sensitivity, while sector‑specific commodity and regulatory risks remain elevated.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (RSI, MACD, SMA alignment)
  • Strong cash flow supporting dividend and buyback
  • Price near support with upside to resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Robust revenue growth and high operating margins
  • Potential upside from AES acquisition and share repurchase

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage relative to equity
  • Energy sector exposure to commodity price swings
  • Sustainable dividend but modest long‑term yield

Key Metrics & Analysis

Financial Health

Revenue Growth26.90%
Profit Margin24.93%
P/E Ratio18.8
ROE9.01%
ROA5.35%
Debt/Equity28.93
P/B Ratio1.6
Op. Cash Flow$5.1B
Free Cash Flow$1.8B
Industry P/E20.6

Technical Analysis

TrendBullish
RSI67.0
Support$55.12
Resistance$63.06
MA 20$59.47
MA 50$56.15
MA 200$55.25
MACDBullish
VolumeStable
Fear & Greed Index76.7

Valuation

Fair Value$98.87
Target Price$66.04
Upside/Downside6.12%
GradeUndervalued
TypeBlend
Dividend Yield1.06%

Risk Assessment

Beta0.67
Volatility30.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.